Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-1.50 Mil
% of Total Estimate Gain
-8.96%

HARTFORD SMALL COMPANY HLS FUND's Haemonetics Corp Holding Summary

As of 2025-03-31, HARTFORD SERIES FUND INC held - shares of Haemonetics Corp(HAE), totaling N/A. This investment constitutes 0% of their stock portfolio, and HARTFORD SERIES FUND INC now holds 0% of the outstanding Haemonetics Corp(HAE) stock.

The initial trade took place in 2019Q3. And since then HARTFORD SMALL COMPANY HLS FUND has made 2 purchases of HAE, at an average price of $97.39, for a total of 171,922.00 shares. In addition, there have been 11 sales at an average price of $88.66 for 171,922.00 shares. Based on historical transaction data and HAE's current price of $72.55, HARTFORD SMALL COMPANY HLS FUND's estimated gain on his HAE holdings is $-1.50 Mil, reflecting a -8.96% gain to date.

HARTFORD SMALL COMPANY HLS FUND HAE ($72.55) Holding Chart

HARTFORD SMALL COMPANY HLS FUND HAE ($72.55) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1